Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety, Efficacy and Pharmacokinetics of ALD403

ClinicalTrials.gov ID: NCT01772524

Public ClinicalTrials.gov record NCT01772524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety, pharmacokinetics and efficacy of a single dose of ALD403 in the prevention of migraine headache in frequent episodic migraineurs for 24 weeks.

Study identification

NCT ID
NCT01772524
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Alder Biopharmaceuticals, Inc.
Industry
Enrollment
163 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2013 (Type not available)
Primary completion
Dec 2013 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
Jan 8, 2016

2013 – 2014

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Premiere Research Phoenix Arizona 85027 —
ACT Trials Anaheim California 92801 —
Collaborative Neuroscience Network, Inc. Long Beach California 90806 —
Medical Center for Clinical Research San Diego California 92108 —
San Francisco Clinical Research San Francisco California 94109 —
CA Medical Clinic for Headache Santa Monica California 90404 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
MD Clinical Hallandale Florida 33009 —
Miami Research Miami Florida 33143 —
Segal Institute for Clinical Research North Miami Florida 33161 —
Palm Beach Research Center West Palm Beach Florida 33409 —
Boston Clinical Trials Roslindale Massachusetts 02131 —
MedVadis Research Watertown Massachusetts 02472 —
Michigan Headache & Neurological Institute Ann Arbor Michigan 48104 —
Clinvest Springfield Missouri 65807 —
SPRI Brooklyn New York 11235 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Wake Research Raleigh North Carolina 27612 —
Community Research Cincinnati Ohio 45255 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
ClinSearch Chattanooga Tennessee 37421 —
Neurology Associates of Arlington Arlington Texas 76017 —
Premiere Research Austin Texas 78705 —
CRI Lifetree Salt Lake City Utah 84106 —
Tidewater Integrated Medical Research Virginia Beach Virginia 23454 —
Seattle Women's: Health, Research, Gynecology Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01772524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01772524 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →